the aid library

LIST OPTIONS

Filter

3949

Download (564)

View PDF (1100)

Nepal Health Sector Strategy Implementation Plan 2016-2021
recommended

Governement of Nepal, Ministry of Health (2017) C1

Download (239)

View PDF (497)

Instruments internationaux sur l’utilisation des antimicrobiens dans les secteurs de la santé humaine, des animaux et des plantes

the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO) (2020) C_WHO

La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr... more

Download (1784)

View PDF (1055)

DRC: Guide technique de prevention et prise en charge du paludisme (Hôpital général de référence)

République Démocratique du Congo, Ministère de la Santé Publique, Programme National de la Lutte contre le Paludisme (PNLP) (2012) C1

Document opérationnel technique sur la prévention et la prise en charge des cas de paludisme en République Démocratique du Congo (RDC)

Download (235)

View PDF (195)

Spécifications techniques des équipements de protection individuelle contre la maladie à coronavirus 2019 (COVID 19)
recommended

Organisation Mondiale de la Santé OMS (2020) C_WHO

Ce document fournit des orientations provisoires sur la qualité, les caractéristiques de performance et les normes connexes des équipements de protection individuelle (EPI) à utiliser dans le contexte de COVID-19. Il s'agit notamment des dispositifs médicaux prioritaires de l'OMS, à savoir : l... more

Download (1003)

View PDF (1071)

Pedoman Tatalaksana Pencegahan Penyakit Kardiovaskular pada Perempuan

Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al., Indonesian Heart Association (2015) C1

Guidelines for the Prevention of Cardiovascular Disease in Women in Indonesia

Download (255)

View PDF (272)

Chagas disease key facts

International Federation of Red Cross and Red Crescent Societies IFRC IFRC (2022) C1

About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is found mainly in endemic areas of 21 Latin American countries.

Download (308)

View PDF (352)

Rwanda: HEALTH SECTOR ANNUAL REPORT July 2014-June 2015

Ministry of Health, Rwanda (2015) C2

For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable ... more

Download (1089)

View PDF (2818)

Fever Diagnostic Technology Landscape
recommended

UNITAID World Health Organisation (WHO) (2018) C_WHO

1st edition. Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ... more

Download (1197)

View PDF (1251)

Health Systems in Action: An eHandbook for Leaders and Managers - CHAPTER 8 - Managing Medicines And Health Products

Malcolm Clark; Andy Barraclough Management Sciences for Health (2010) C1

Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit... more

External Link

External Link (225)

Paludisme : traitement et prise en charge – Recommandations VIDAL

VIDAL (2025) C2

La page du site VIDAL intitulée « Paludisme : traitement – Recommandations » présente les recommandations actuelles pour la prise en charge du paludisme. Elle détaille les différents traitements selon le type de paludisme (P. falciparum ou non), la gravité de l'infection (simple ou sévère... more

Download (183)

View PDF (252)

COPD (acute exacerbation): antimicrobial prescribing

National Institute for Communicable Disease (NICE) National Institute for Communicable Disease (NICE) (2019) CC2

The NICE guideline NG114 provides recommendations on antimicrobial therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), aiming to optimize antibiotic use and minimize the development of antibiotic resistance.

Download (346)

View PDF (559)

Guidance on the prioritization of insecticide-treated nets in situations where resources are limited

World Health Organisation (WHO) (2023) C_WHO

In the context of limited resources, national malaria programmes may need to decide on how to prioritize all WHO-recommended interventions . This guidance document has been developed to support national malaria programmes in prioritization decisions, specifically on the deployment scope and product ... more

Download (365)

View PDF (400)

Democratic Republic of Timor-Leste Ministry of Health - Comprehensive TB Guidelines for National Tuberculosis Program, V Edition

Government of Timor-Leste; World Health Organization (2023) CC

The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death. The salient observations are as follows: In 2018, 487 (12.5%) of the... more

Download (1454)

View PDF (3201)

Guidelines For Laboratory And Field Testing Of Long-Lasting Insecticidal Mosquito Nets

World Health Organization (2005) C_WHO

Download (1559)

View PDF (3267)

Integrated TB-HIV Outpatient Clinical Service (OPC) QA/QI Checklist

Family Health International FHI (2007) C1

This field guide is designed for use by FHI 360 staff and partner organizations responsible for ensuring quality clinical services, at both facility and non-facility levels. The guide provides general information on how to organize, implement and follow up on quality assurance/quality improvement cl... more

Download (11617)

View PDF (2700)

Sterilization Manual for Health Centers

Silvia I. Acosta-Gnass and Valeska de Andrade Stempliuk PAHO; USAID (2009) C_WHO

Download (334)

View PDF (472)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (385)

View PDF (335)

International health regulations (‎2005)‎: state party self-assessment annual reporting tool, 2nd ed

World Health Organization WHO (2022) C_WHO

Second edition. AVailable in English, French, Spanish, Russian, Chinese and Portuguese

Download (1589)

View PDF (2821)

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

Download (422)

View PDF (643)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Nepal Health Sector Strategy Implementation Plan 2016-2021 recommended

Spécifications techniques des équipements de protection individuelle contre la maladie à coronavirus 2019 (COVID 19) recommended

Fever Diagnostic Technology Landscape recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

Nepal Health Sector Strategy Implementation Plan 2016-2021
recommended

Spécifications techniques des équipements de protection individuelle contre la maladie à coronavirus 2019 (COVID 19)
recommended

Fever Diagnostic Technology Landscape
recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended